Twist Historical Cash Flow
TWST Stock | USD 48.17 1.06 2.15% |
Analysis of Twist Bioscience cash flow over time is an excellent tool to project Twist Bioscience Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 10.3 M or Depreciation of 33 M as it is a great indicator of Twist Bioscience ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Twist Bioscience Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Twist Bioscience Corp is a good buy for the upcoming year.
Twist |
About Twist Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Twist balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Twist's non-liquid assets can be easily converted into cash.
Twist Bioscience Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Twist Bioscience Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Twist Bioscience operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Twist Bioscience's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At this time, Twist Bioscience's Change To Inventory is comparatively stable compared to the past year. Change In Working Capital is likely to gain to about 16.2 M in 2024, despite the fact that Change In Cash is likely to grow to (57.1 M).
Twist Bioscience cash flow statement Correlations
Click cells to compare fundamentals
Twist Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Twist Bioscience cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Sale Purchase Of Stock | (2.4M) | (10.8M) | (7.8M) | (4.4M) | (4.0M) | (3.8M) | |
Change To Inventory | (5.0M) | (19.5M) | (7.5M) | 7.2M | 8.0M | 8.4M | |
Investments | (104.8M) | 183.7M | (117.2M) | 50.6M | (3.1M) | (3.2M) | |
Change In Cash | 46.8M | 373.1M | (87.1M) | (91.0M) | (60.1M) | (57.1M) | |
Stock Based Compensation | 17.1M | 37.0M | 79.7M | 30.3M | 50.9M | 28.3M | |
Free Cash Flow | (152.1M) | (139.3M) | (226.2M) | (170.3M) | (69.2M) | (72.6M) | |
Change In Working Capital | (25.2M) | (9.4M) | (5.4M) | (1.0M) | 15.4M | 16.2M | |
Begin Period Cash Flow | 47.4M | 94.2M | 467.4M | 380.3M | 289.3M | 177.3M | |
Total Cashflows From Investing Activities | (104.8M) | (114.7M) | 156.2M | (232.9M) | (209.6M) | (199.2M) | |
Other Cashflows From Financing Activities | 13.9M | 19.5M | 10.0M | 5.3M | 10.9M | 10.3M | |
Depreciation | 6.7M | 9.8M | 16.5M | 29.3M | 31.4M | 33.0M | |
Other Non Cash Items | (707K) | 1.9M | 2.7M | 4.0M | 46.9M | 49.2M | |
Capital Expenditures | 9.9M | 27.1M | 101.9M | 27.8M | 5.1M | 4.8M | |
Total Cash From Operating Activities | (142.3M) | (112.2M) | (124.4M) | (142.5M) | (64.1M) | (67.3M) | |
Change To Account Receivables | (14.3M) | (2.2M) | (9.6M) | (4.3M) | 8.4M | 8.9M | |
Change To Operating Activities | 7.7M | (442K) | 3.8M | 4.4M | 5.1M | 2.8M | |
Net Income | (139.9M) | (152.1M) | (217.9M) | (204.6M) | (208.7M) | (219.2M) | |
Total Cash From Financing Activities | 303.7M | 329.2M | 270.5M | 911K | 6.9M | 6.5M | |
End Period Cash Flow | 94.2M | 467.4M | 380.3M | 289.3M | 229.1M | 201.5M | |
Change To Netincome | 11.6M | 17.2M | 37.1M | 82.3M | 94.7M | 99.4M | |
Change To Liabilities | 12.3M | (1.7M) | 19.0M | 7.4M | 8.5M | 6.6M | |
Issuance Of Capital Stock | 156.2M | 295.6M | 323.9M | 269.8M | (2K) | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.